Wenyan Zhong

23.2k citations
33 papers · 992 indexed · 1 hit paper · h-index 15
Topics
Cancer Cells and Metastasis (3 papers)Cancer Genomics and Diagnostics (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)

In The Last Decade

Wenyan Zhong

29 papers receiving 963 citations

Hit Papers

Pembrolizumab Versus Placebo as Second-Line Therapy in Pa...202220262023202420224080120

Peers

Wenyan Zhong
Comparison fields: 5 of 110
  • Molecular Biology 400
  • Oncology 390
  • Immunology 170
  • Surgery 128
  • Epidemiology 118
Replace Xing Gu with:
Xing Gu China
Guifang Yang China
Wenjie Ma China
Jirun Peng China
Idrees Mian United States
Mingsheng Zhang China
Ganiraju C. Manyam United States
Yixuan Yang China
Takuya Fukazawa Japan
Wenyan Zhong relative to Xing Gu China Xing Gu's profile →
Citations per field
00.5×3.7×
Xing Gu · 1×
Citations per year

Countries citing papers authored by Wenyan Zhong

Since Specialization
Citations

This map shows the geographic impact of Wenyan Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Zhong more than expected).

Fields of papers citing papers by Wenyan Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Zhong. The network helps show where Wenyan Zhong may publish in the future.

Co-authorship network of co-authors of Wenyan Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Zhong. A scholar is included among the top collaborators of Wenyan Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Zhong. Wenyan Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 7
6 4
7 3
8
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trialbreakdown →
127
9 3
10 113
11 22
12 7
13 9
14 110
15 45
16 55
17 82
18 7
19 29
20 27

About Wenyan Zhong

Wenyan Zhong is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 992 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (390 citations), Hepatology (99 citations) and Immunology (170 citations). Wenyan Zhong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include N H Georgopapadakou, Jeremy S. Myers, Marc Damelin, Puja Sapra, Christine Huard, Robert V. Martinez, Janet Paulsen, Heather H. Shih, Stephen J. Benkovic and Edward Rosfjord. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026